NH
This startup provides an AI-powered diagnostic tool that predicts hospital-acquired infections, including COVID-19, before patients test positive. The platform automates infection prevention and control (IPC) investigations, helping healthcare providers identify at-risk patients for screening or isolation and reduce transmission.
Updated 2 months ago
Funding
€1M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
AABVCXMVFounders
Product
Features
- This startup provides an AI-powered diagnostic tool that predicts hospital-acquired infections, including COVID-19, before patients test positive. The platform automates infection prevention and control (IPC) investigations, helping healthcare providers identify at-risk patients for screening or isolation and reduce transmission.